Bonhomme Vincent, Doll Anne, Dewandre Pierre Yves, Brichant Jean François, Ghassempour Keyvan, Hans Pol
University Department of Anesthesia and Intensive Care Medicine, CHR de la Citadelle, Liege University Hospital, Liege, Belgium.
J Neurosurg Anesthesiol. 2002 Jan;14(1):1-6. doi: 10.1097/00008506-200201000-00001.
This study evaluates the efficacy and side effects of a low dose of epidural morphine combined with clonidine for postoperative pain relief after lumbar disc surgery. In 36 of 51 patients who accepted the procedure, an epidural catheter was inserted (L1-L2 level). General anesthesia was induced with propofol and sufentanil, and maintained with sevoflurane in O2/N2O. After emergence from anesthesia, epidural analgesia was initiated according to two randomly assigned protocols: 1 mg of morphine with 75 microg of clonidine (Group M) or 12.5 mg of bupivacaine with 75 microg of clonidine (Group B), in 10 mL saline. Piritramide was administered during the first postoperative 24 hours using a patient-controlled analgesia device (PCA). The following parameters were recorded: piritramide consumption during the first 24 hours; pain at rest during the first postoperative hours (D0), during the first night (D1), and during the first mobilization; [visual analogue scale (VAS)]; and the occurrence of drowsiness, motor blockade, respiratory depression, nausea, vomiting, itching, micturition problems, and bladder catheterization during D0 and D1. Epidural administration of morphine-clonidine significantly improved postoperative pain relief and reduced piritramide consumption as compared to epidural bupivacaine-clonidine. Side effects did not differ between groups except for a higher incidence of micturition problems in Group M during D1. The occurrence of bladder catheterization was not significantly higher in that group. We conclude that a low dose of epidural morphine combined with clonidine offers a better postoperative analgesia than does bupivacaine-clonidine. The excellent analgesic conditions were obtained at the expense of a higher incidence of difficulties in initiating micturition.
本研究评估低剂量硬膜外吗啡联合可乐定用于腰椎间盘手术后疼痛缓解的疗效及副作用。51例接受该手术的患者中,36例在L1 - L2水平插入硬膜外导管。采用丙泊酚和舒芬太尼诱导全身麻醉,并用七氟醚在O2/N2O中维持麻醉。麻醉苏醒后,根据两种随机分配的方案开始硬膜外镇痛:1 mg吗啡加75 μg可乐定(M组)或12.5 mg布比卡因加75 μg可乐定(B组),溶于10 mL生理盐水中。术后第1个24小时使用患者自控镇痛装置(PCA)给予匹米诺定。记录以下参数:术后第1个24小时内匹米诺定的用量;术后第1小时(D0)、第1个夜间(D1)和首次活动时的静息疼痛[视觉模拟评分法(VAS)];以及D0和D1期间嗜睡、运动阻滞、呼吸抑制、恶心、呕吐、瘙痒、排尿问题和导尿的发生情况。与硬膜外布比卡因 - 可乐定相比,硬膜外给予吗啡 - 可乐定显著改善了术后疼痛缓解并减少了匹米诺定的用量。除M组在D1期间排尿问题发生率较高外,两组间副作用无差异。该组导尿的发生率无显著升高。我们得出结论,低剂量硬膜外吗啡联合可乐定比布比卡因 - 可乐定提供更好的术后镇痛效果。以排尿启动困难发生率较高为代价获得了良好的镇痛效果。